R&D Network on personalized cancer medicine

Event Details

Welcome to R&D Network on personalized cancer medicine

We invite our members to this year’s last R&D Network – topic is the different views on personalized cancer medicine


14:00-14:30 Registration and coffee

14:30-14:45 Welcome and update – Ketil Widerberg, general manager Oslo Cancer Cluster

14:45- 15:15  Norwegian Cancer Genomics Consortium – an update – Prof. Ola Myklebost

15:15 – 15:40 Personalized medicine and its relevance to cancer immunotherapy – Richard Stratford, CEO of Oncoimmunity

15:40-16:00 Ethical and societal implications of personalized medicine – Sigrid Thoresen, senior advisor, The Norwegian Biotechnology Advisory Board

16:00 – 16:20 Legal regulations of personalized cancer medicine – Heidi B. Bentzen, PhD Candidate, Centre for Medical Ethics and The Norwegian Research Center for Computers and Law, University of Oslo

16:20-16:40 Personalized cancer medicine – the investor’s perspective – Johan Christenson, HealthCap

16:40 Wrap up and Networking with refreshments


Registration or Question may be directed to: mbl@oslocancercluster.no


Print This Post